LMF1 expression based on
|
Comparison | Statistical significance |
Normal-vs-Primary | 1.004040E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.558000E-01 |
Normal-vs-Stage2 |
3.133500E-02 |
Normal-vs-Stage3 |
1.017470E-03 |
Normal-vs-Stage4 |
5.144400E-02 |
Stage1-vs-Stage2 |
9.064300E-03 |
Stage1-vs-Stage3 |
7.901400E-03 |
Stage1-vs-Stage4 |
1.279560E-01 |
Stage2-vs-Stage3 |
1.80068999999783E-05 |
Stage2-vs-Stage4 |
1.681970E-03 |
Stage3-vs-Stage4 |
9.084000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.180400E-03 |
Normal-vs-AfricanAmerican |
5.939200E-01 |
Normal-vs-Asian |
9.230200E-01 |
Caucasian-vs-AfricanAmerican |
1.826840E-01 |
Caucasian-vs-Asian |
7.392300E-02 |
AfricanAmerican-vs-Asian |
6.377600E-01 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.478600E-01 |
Normal-vs-Female |
1.793730E-02 |
Male-vs-Female |
3.453900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.937200E-01 |
Normal-vs-Age(41-60Yrs) |
2.015600E-01 |
Normal-vs-Age(61-80Yrs) |
1.415600E-01 |
Normal-vs-Age(81-100Yrs) |
2.138900E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.994400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.328200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.219250E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.879000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.550400E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.352000E-01 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Classical-VS-Tall |
1.08140052468286E-10 |
Classical-VS-Follicular |
3.29310001490057E-09 |
Classical-VS-Other |
5.229800E-01 |
Classical-VS-Normal |
8.459500E-03 |
Tall-VS-Follicular |
1.62447832963153E-12 |
Tall-VS-Other |
8.139500E-02 |
Tall-VS-Normal |
1.67010849594362E-12 |
Follicular-VS-Other |
2.517000E-01 |
Follicular-VS-Normal |
1.220330E-03 |
Other-VS-Normal |
9.633400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.712000E-01 |
Normal-vs-N1 |
1.731610E-01 |
N0-vs-N1 |
5.709700E-02 |
|
|